Increased Serum Dihomo-γ-linolenic Acid Levels Are Associated with Obesity, Body Fat Accumulation, and Insulin Resistance in Japanese Patients with Type 2 Diabetes
Overview
Affiliations
Objective To clarify the associations between serum omega-6 (n-6) and omega-3 (n-3) polyunsaturated fatty acid (PUFA) levels and obesity-related metabolic abnormalities in patients with type 2 diabetes. Methods and Materials Data from 225 Japanese patients with type 2 diabetes were cross-sectionally analyzed. The serum levels of n-6 PUFAs [dihomo-γ-linolenic acid (DGLA) and arachidonic acid (AA)] and n-3 PUFAs (eicosapentaenoic acid and docosahexaenoic acid) were measured, and the estimated Δ-5 desaturase (D5D) activity was calculated based on the AA to DGLA ratio. The associations between the composition of PUFAs and obesity-related parameters, including the body mass index (BMI), waist circumference, alanine amino transferase (ALT) level, homeostatic model assessment of insulin resistance (HOMA-IR), and body fat percentage, as measured by a bioelectrical impedance analysis, were analyzed. Results Among the PUFAs, the DGLA level had the strongest correlations with BMI (p<0.001), waist circumference (p<0.001), ALT level (p<0.001), HOMA-IR (p<0.001), and body fat percentage (p<0.01). AA was positively correlated and D5D was negatively correlated with several obesity-related parameters, while n-3 PUFAs did not have a constant correlation. A multivariate regression analysis revealed that the DGLA level was an independent determinant for HOMA-IR (β=0.195, p=0.0066) after adjusting for sex, age, BMI, and the ALT, triglyceride, and HbA1c levels. Conclusion A high serum DGLA level was associated with obesity, body fat accumulation, a high ALT level, and insulin resistance in patients with type 2 diabetes. The measurement of the serum PUFA levels may be useful for evaluating metabolic abnormalities and estimating the dietary habits of patients.
Mochizuki K, Higa M, Ikehara K, Ichijo T, Hirose T Diabetol Int. 2025; 16(1):107-114.
PMID: 39877445 PMC: 11769884. DOI: 10.1007/s13340-024-00760-3.
Agagunduz D, Yesildemir O, Kocyigit E, Kocak T, Ozen Unaldi B, Ayakdas G Nutrients. 2024; 16(22).
PMID: 39599599 PMC: 11597274. DOI: 10.3390/nu16223812.
Relationship between Polyunsaturated Fatty Acid Metabolism and Atherosclerosis.
Liu Q, Liu Z, Wu D, Wang S Rev Cardiovasc Med. 2024; 25(4):142.
PMID: 39076540 PMC: 11263998. DOI: 10.31083/j.rcm2504142.
Sun Y, Zhou W, Zhu M Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065745 PMC: 11279973. DOI: 10.3390/ph17070895.
Association of dietary nutrient intake with type 2 diabetes: A Mendelian randomization study.
Kang R, Guo D, Wang J, Xie Z Medicine (Baltimore). 2024; 103(19):e38090.
PMID: 38728475 PMC: 11081547. DOI: 10.1097/MD.0000000000038090.